Redefining IL11 as a regeneration-limiting hepatotoxin and therapeutic target in acetaminophen-induced liver injury

Author:

Widjaja Anissa A.1ORCID,Dong Jinrui1ORCID,Adami Eleonora1,Viswanathan Sivakumar1ORCID,Ng Benjamin12ORCID,Pakkiri Leroy S.3,Chothani Sonia P.1,Singh Brijesh K.1ORCID,Lim Wei Wen2ORCID,Zhou Jin1,Shekeran Shamini G.1,Tan Jessie12,Lim Sze Yun2ORCID,Goh Joyce1,Wang Mao1ORCID,Holgate Robert4,Hearn Arron4ORCID,Felkin Leanne E.5ORCID,Yen Paul M.1,Dear James W.6ORCID,Drum Chester L.789ORCID,Schafer Sebastian12,Cook Stuart A.1210ORCID

Affiliation:

1. Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.

2. National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.

3. Cardiac Department, National University Hospital, Singapore 119074, Singapore.

4. Abzena, Babraham Research Campus, Babraham, Cambridge CB22 3AT, UK.

5. National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK.

6. Pharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK.

7. Cardiovascular Research Institute, National University Health System, Singapore 119228, Singapore.

8. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.

9. Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.

10. MRC-London Institute of Medical Sciences, Hammersmith Hospital Campus, London W12 0NN, UK.

Abstract

Inhibition of IL11 signaling limits drug-induced liver damage and promotes hepatic regeneration in a mouse model.

Funder

National Medical Research Council

National University of Singapore

NUS-Agilent Hub for Translation and Capture

Fondation Leducq

Tanoto Foundation

MRC London institute of Medical Sciences

Goh Foundation

FUNDING

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3